CLOTRIMAZOLE EXTERNAL CREAM

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

CLOTRIMAZOLE

可用日期:

TARO PHARMACEUTICALS INC

ATC代码:

G01AF02

INN（国际名称）:

CLOTRIMAZOLE

剂量:

1%

药物剂型:

CREAM

组成:

CLOTRIMAZOLE 1%

给药途径:

TOPICAL

每包单位数:

15G

处方类型:

OTC

治疗领域:

AZOLES

產品總結:

Active ingredient group (AIG) number: 0110231001; AHFS:

授权状态:

APPROVED

授权日期:

2015-07-15

产品特点

_ _
_CLOTRIMAZOLE VAGINAL 6 _
_CLOTRIMAZOLE VAGINAL 3 _
_CLOTRIMAZOLE EXTERNAL CREAM _
_CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM _
_CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM _
_ PAGE 1 OF 29 _
PRODUCT MONOGRAPH
CLOTRIMAZOLE VAGINAL 6
(Clotrimazole Vaginal Cream USP 1%)
CLOTRIMAZOLE VAGINAL 3
(Clotrimazole Vaginal Cream USP 2%)
CLOTRIMAZOLE EXTERNAL CREAM
(Clotrimazole
Cream USP 1%) CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM
(Clotrimazole
Cream USP 1%)
CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL
CREAM
(Clotrimazole
Cream USP 2%)
ANTIFUNGAL AGENT
Taro Pharmaceuticals
Inc.
Date of Revision:
130 East Drive
April 29, 2022
Brampton, Ontario
L6T 1C1
Control # 263251
_ _
_CLOTRIMAZOLE VAGINAL 6 _
_CLOTRIMAZOLE VAGINAL 3 _
_CLOTRIMAZOLE EXTERNAL CREAM _
_CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM _
_CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM _
_ PAGE 2 OF 29 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................................
3
SUMMARY
PRODUCT
INFORMATION
............................................................................................
3
INDICATIONS
AND
CLINICAL
USE..................................................................................................
3
CONTRAINDICATIONS
.....................................................................................................................
4
WARNINGS
AND
PRECAUTIONS
.....................................................................................................
4
ADVERSE
REACTIONS
.....................................................................................................................
5
DRUG
INTERACTIONS
......................................................................................................................
6
DOSAGE
AND
ADMINISTRATION
...................................................................................................
6
OVERDOSAGE
...................................................................................................